Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cao D et al. - The findings indicate that SALL4 is a novel sensitive and relatively specific marker for testicular GCTs. SALL4 is a more sensitive marker than AFP and glypican-3 for YST.

Related Articles

Metachronous bilateral testicular germ cell tumors: Report of two cases
Journal of Cancer Research and Therapeutics, 10/28/09    Relevance Score: 69%

Clinicopathological Study of Regressed Testicular Tumors (Apparent Extragonadal Germ Cell Neoplasms)
The Journal of Urology, 10/22/09    Relevance Score: 69%

Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma
Human Pathology, 10/22/09    Relevance Score: 68%

Spermatocytic seminoma with rhabdomyosarcomatous differentiation: A case report with a review of the literature
Journal of Cancer Research and Therapeutics, 10/28/09    Relevance Score: 65%

Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors
Therapeutic Advances in Urology, 10/08/09    Relevance Score: 64%

Today in Testis/Scrotum...keeping you current

A gene signature of primary tumor identifies metastasized seminoma
Urologic Oncology: Seminars and Original Investigations, 12/09/09

Nonseminomatous Germ Cell Tumor of the Testes Metastatic to the Corpus Cavernosum of the Penis
Urology, 12/08/09

Effect of Testicular Sperm Extraction Outcome on Sexual Function in Patients With Male Factor Infertility
Urology, 12/07/09